As of Feb 17
| +0.25 / +0.34%|
The 14 analysts offering 12-month price forecasts for NuVasive Inc have a median target of 79.50, with a high estimate of 85.00 and a low estimate of 73.00. The median estimate represents a +7.11% increase from the last price of 74.22.
The current consensus among 18 polled investment analysts is to Buy stock in NuVasive Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.